Quarterly report · Q3
7745.TEDINET S100Q869
Period2022-04-01 → 2022-12-31
Filed2023-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥42.2bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥51.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥37.3bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥4.7bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥3.6bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥4.9bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥5.6bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.7bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥4.9bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.6bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.5bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.6bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.2bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.5bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥2.5bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥68.1bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥59.2bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥57.2bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥37.2bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥32.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥30.9bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥27.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥25.4bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.4bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.9bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥128.43 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.97 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.92 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥104.55 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.52 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥128.31 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥172.66 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥104.38 | 2021-04-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 45.2% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.6% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 98
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥21.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥21.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥1.9bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.7bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.4bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥352m |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥486m |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥6.8bn |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥6.8bn |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥1m |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥31m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥6.3bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥3.8bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2.5bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥451m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥7.4bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥328m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥7.0bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥242m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥730m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥729m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥0 |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥102m |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥7.2bn |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥7.2bn |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥3m |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥13.8bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥11.0bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2.9bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥541m |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥13.1bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.1bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥9.0bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.3bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.3bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥25.6bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥19.9bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥5.8bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.6bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥34.5bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥18.4bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥16.1bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥3.8bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.3bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥18.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥18.1bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥1.5bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥2.9bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥2.7bn |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥177m |
| jpcrp040300-q3r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥221m |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥5.5bn |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥5.5bn |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥10m |
| jpcrp040300-q3r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥135m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥5.2bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥3.2bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥2.0bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥345m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥6.2bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥394m |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥5.8bn |
| jpcrp040300-q3r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥308m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥696m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥696m |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥0 |
| jpcrp040300-q3r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥43m |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥6.0bn |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥6.0bn |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥4m |
| jpcrp040300-q3r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥875m |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥13.6bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥11.2bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥2.4bn |
| jpcrp040300-q3r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥223m |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥11.8bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥4.2bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥7.6bn |
| jpcrp040300-q3r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥1.9bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥3.5bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥3.5bn |
| jpcrp040300-q3r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥22.4bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥17.8bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥4.6bn |
| jpcrp040300-q3r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥833m |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥29.5bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥16.1bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥13.5bn |
| jpcrp040300-q3r_E02344-000Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥3.2bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥3.5bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥3.5bn |
| jpcrp040300-q3r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 456
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)矢 嶋 泰 久 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)宮 一 行 男 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 37325000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 42217000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 51736000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 3685000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 4873000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 5604000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 2160000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 3523000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 3573000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 2895000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 4624000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 4493000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 25442000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 30901000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 27041000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 57199000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 68125000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 59239000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 104.55 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 128.43 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 172.92 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 104.38 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 128.31 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 172.66 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.396 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.452 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.408 | |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 38.52 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 74.97 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 27845208 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 27845208 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 27845208 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 27845208 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 117000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 27616100 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 276161 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 112108 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 27845208 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 276161 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 117000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |